SEK 77.6
(-0.59%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 11.94 Billion | 10.52 Billion | 8.95 Billion | 8.13 Billion | 7.6 Billion | 6.71 Billion |
Cost of Revenue | 3.03 Billion | 2.72 Billion | 2.21 Billion | 1.91 Billion | 1.96 Billion | 1.82 Billion |
Gross Profit | 8.91 Billion | 7.79 Billion | 6.74 Billion | 6.21 Billion | 5.64 Billion | 4.89 Billion |
Operating Expenses | 1.09 Billion | -943 Million | 817 Million | 676 Million | 664 Million | 595 Million |
Selling, General and Administrative Expenses | 1.08 Billion | -1.01 Billion | 817 Million | 676 Million | 664 Million | 592 Million |
Research and Development Expenses | - | 1.10 | 2.50 | 1.07 | 1.79 | 1.73 |
Other Expenses | - | 76 Million | -58 Million | -91 Million | 7 Million | 3 Million |
Cost and Expenses | 4.12 Billion | 1.78 Billion | 3.02 Billion | 2.59 Billion | 2.63 Billion | 2.41 Billion |
Operating Income | 7.81 Billion | 13.62 Billion | 23.47 Billion | 10.27 Billion | 15.89 Billion | 13.17 Billion |
Interest Expense | 4.48 Billion | 2.25 Billion | 1.82 Billion | 1.51 Billion | 1.52 Billion | 1.14 Billion |
Income Tax Expense | -1.25 Billion | 1.99 Billion | 3.19 Billion | 1.8 Billion | 2.65 Billion | 1.89 Billion |
Earnings before Tax | -8.95 Billion | 12.98 Billion | 22.78 Billion | 9.08 Billion | 14.18 Billion | 12.06 Billion |
Net Income | -6.74 Billion | 10.17 Billion | 18.5 Billion | 6.64 Billion | 8.95 Billion | 9.3 Billion |
Earnings Per Share Basic | -5.14 | 9.09 | 16.54 | 6.15 | 8.29 | 8.62 |
Earnings Per Share Diluted | -4.98 | 9.09 | 16.54 | 6.13 | 8.29 | 8.62 |
Weighted Average Shares Outstanding | 1.11 Billion | 1.11 Billion | 1.11 Billion | 1.07 Billion | 1.07 Billion | 1.07 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.15 Billion | 1.11 Billion | 1.11 Billion | 1.08 Billion | 1.07 Billion | 1.08 Billion |
Gross Margin | 0.75 | 0.74 | 0.75 | 0.76 | 0.74 | 0.73 |
EBIT Margin | 0.66 | 1.30 | 2.63 | 1.27 | 2.09 | 1.98 |
Profit Margin | -0.56 | 0.97 | 2.07 | 0.82 | 1.18 | 1.39 |
EBITDA | 7.88 Billion | 13.67 Billion | 23.52 Billion | 10.31 Billion | 15.93 Billion | 4.31 Billion |
Earnings Before Tax Margin | 0.65 | 1.29 | 2.62 | 1.26 | 2.09 | 1.96 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 3.22 Billion | 3.18 Billion | 3.12 Billion | 3.08 Billion | 11.94 Billion | 3.01 Billion |
Cost of Revenue | 726 Million | 1.28 Billion | 864 Million | 815 Million | 3.03 Billion | 676 Million |
Gross Profit | 2.5 Billion | 1.9 Billion | 2.26 Billion | 2.27 Billion | 8.91 Billion | 2.34 Billion |
Operating Expenses | 326 Million | 338 Million | 290 Million | 303 Million | 1.09 Billion | 250 Million |
Selling, General and Administrative Expenses | 237 Million | 278 Million | 283 Million | 290 Million | - | 250 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 89 Million | -7 Million | -290 Million | -303 Million | -1.09 Billion | 1 Million |
Cost and Expenses | 1.05 Billion | 1.56 Billion | 1.15 Billion | 1.11 Billion | 4.12 Billion | 926 Million |
Operating Income | 2.17 Billion | 1.62 Billion | 1.97 Billion | 1.97 Billion | 7.81 Billion | 2.56 Billion |
Interest Expense | - | - | - | 922 Million | 4.48 Billion | 881 Million |
Income Tax Expense | 154 Million | 188 Million | 202 Million | -894 Million | -1.25 Billion | -43 Million |
Earnings before Tax | -36 Million | 957 Million | -789 Million | -6.94 Billion | -11.27 Billion | -1.1 Billion |
Net Income | -294 Million | 772 Million | -594 Million | -3.83 Billion | -5.75 Billion | -1.06 Billion |
Earnings Per Share Basic | -0.25 | 0.66 | -0.51 | -3.32 | - | -0.92 |
Earnings Per Share Diluted | -0.25 | 0.62 | -0.51 | -3.32 | - | -0.92 |
Weighted Average Shares Outstanding | 1.17 Billion | 1.17 Billion | 1.16 Billion | 1.15 Billion | 1.15 Billion | 1.15 Billion |
Weighted Average Shares Outstanding (Diluted) | 1.17 Billion | 1.24 Billion | 1.16 Billion | 1.15 Billion | 1.15 Billion | 1.15 Billion |
Gross Margin | 0.78 | 0.60 | 0.72 | 0.74 | 0.75 | 0.78 |
EBIT Margin | 0.68 | 0.52 | 0.64 | 0.64 | - | 0.86 |
Profit Margin | -0.09 | 0.24 | -0.19 | -1.24 | -0.48 | -0.35 |
EBITDA | 2.2 Billion | 1.64 Billion | 1.99 Billion | 1.99 Billion | - | 2.58 Billion |
Earnings Before Tax Margin | 0.67 | 0.51 | 0.63 | 0.64 | 0.65 | 0.85 |
IMUC
PSHG
HEAL
300080
GSL-PB
ALMDP